Ilaria Milone

发表

Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations.

G. Parati, N. Ticozzi, F. Verde, 2022, Journal of neurology.

A + T ± status across MCI and dementia due to AD: a clinic-based, retrospective study

N. Ticozzi, F. Verde, A. Ratti, 2022, Neurological Sciences.

A + T ± status across MCI and dementia due to AD: a clinic-based, retrospective study

N. Ticozzi, F. Verde, A. Ratti, 2022, Neurological Sciences.

Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations

G. Parati, N. Ticozzi, F. Verde, 2022, Journal of Neurology.

CSF Aβ40 and P-Tau181 Might Differentiate Atypical from Typical AD Phenotypes: Preliminary Evidence

N. Ticozzi, F. Verde, A. Ratti, 2022, Neurodegenerative Diseases.

The Frontal Assessment Battery (FAB) effectively discriminates between MCI and dementia within the clinical spectrum of neurochemically confirmed Alzheimer’s disease

A. Priori, R. Ferrucci, N. Ticozzi, 2022, Frontiers in Psychology.

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis

S. Messina, N. Ticozzi, F. Verde, 2023, Frontiers in Aging Neuroscience.

Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients

S. Messina, N. Ticozzi, F. Verde, 2023, Neurological Sciences.

Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis

S. Messina, N. Ticozzi, F. Verde, 2022, Annals of clinical and translational neurology.

Lower semantic fluency scores and a phonemic-over-semantic advantage predict abnormal CSF P-tau181 levels in Aβ + patients within the Alzheimer’s disease clinical spectrum

A. Priori, R. Ferrucci, N. Ticozzi, 2023, Neurological Sciences.

Phosphorylated tau in plasma could be a biomarker of lower motor neuron impairment in amyotrophic lateral sclerosis.

A. Priori, S. Messina, N. Ticozzi, 2023, Neurological Sciences.

Influence of kidney function and CSF/serum albumin ratio on plasma Aβ42 and Aβ40 levels measured on a fully automated platform in patients with Alzheimer’s disease

N. Ticozzi, F. Verde, A. Ratti, 2023, Neurological Sciences.

Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer’s disease compared to neurological disease controls: a retrospective study on 276 patients

N. Ticozzi, F. Verde, A. Ratti, 2022, Neurological Sciences.

Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis

F. Agosta, N. Ticozzi, F. Verde, 2024, European journal of neurology.